drugset / Trial / NCT01000870

Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513

NCT01000870 ↗

Phase 0 Terminated 6 enrolled Institute for Neurodegenerative Disorders
NaSingle-groupOpen-labelDiagnostic

Summary

The purpose of the study is to evaluate the efficacy and safety of MNI-513 positron emission tomography (PET) for detection/exclusion of cerebral amyloid beta in patients with Alzheimer's disease compared to healthy volunteers.

Timeline

Start
2009-10
Primary completion
2010-09
Completion
2010-09

Outcome

Outcome not reported

Stopped: “Results did not show reason to continue with study”

Drugs

EvaluationDrugModalityDoseRoute
Subject MNI-513 Diagnostic / imaging agent 300 mbq Intravenous

Indications